title: Drug interactions with diosmectite: a study using the artificial stomach-duodenum model.
abstract: Drug interactions with diosmectite, a gastric-protective drug, were studied in vitro using an artificial stomach-duodenum model. The behavior of neutral and ionisable drugs with pKa values ranging between 2 and 8 was monitored to determine the physicochemical characteristics of the interactions. The main neutral (digoxin) and acid (valproic acid) drug substances were moderately fixed by clay (<27%), in a pH-independent manner. Basic compounds with a pKa<7 (dapsone, metronidazole, cimetidine) were strongly fixed in acid medium (?62%), and fully released under neutral conditions. Amphoteric (fluoroquinolones) and basic compounds with a pKa>/=7 (ranitidine, pyrimethamine) were adsorbed by more than 81% by diosmectite in gastric and duodenal compartments. In the part of the model representing the distal duodenum, the potential site for drug absorption, only the active substances which remained positively charged (amphoteric and basic compounds) showed a large reduction (>/=80%) in their available free fraction. Ionisation of drug substances administered per os concomitantly with diosmectite plays a crucial role in these interactions.
authors.affiliation: Laboratoire de Pharmacie Clinique, Faculté de Pharmacie, 92296 Chatenay-Malabry, Paris, France.
authors.forename: N
authors.initials: N
authors.lastname: Castela-Papin
authors.forename: S
authors.initials: S
authors.lastname: Cai
authors.forename: J
authors.initials: J
authors.lastname: Vatier
authors.forename: F
authors.initials: F
authors.lastname: Keller
authors.forename: C H
authors.initials: CH
authors.lastname: Souleau
authors.forename: R
authors.initials: R
authors.lastname: Farinotti
mesh_terms: D000327:Adsorption; D000818:Animals; D000890:Anti-Infective Agents / Q000493:pharmacokinetics; D002927:Cimetidine / Q000493:pharmacokinetics; D003622:Dapsone / Q000493:pharmacokinetics; D004077:Digoxin / Q000493:pharmacokinetics; D004347:Drug Interactions; D004386:Duodenum / Q000378:metabolism / Q000502:physiology*; D024841:Fluoroquinolones; D005753:Gastric Mucosa / Q000378:metabolism; D005765:Gastrointestinal Agents / Q000494:pharmacology*; D006863:Hydrogen-Ion Concentration; D007408:Intestinal Absorption / Q000187:drug effects; D008795:Metronidazole / Q000493:pharmacokinetics; D008954:Models, Biological; D010599:Pharmacokinetics; D017640:Silicates; D013270:Stomach / Q000502:physiology*; D013552:Swine; D014635:Valproic Acid / Q000493:pharmacokinetics
chemical_list: D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D005765:Gastrointestinal Agents; D017640:Silicates; D008795:Metronidazole; D014635:Valproic Acid; D004077:Digoxin; D002927:Cimetidine; D003622:Dapsone; C033214:Smectite